Pharmicell Co., Ltd.
KRX:005690.KS
5300 (KRW) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 56,227.379 | 60,181.807 | 50,893.546 | 37,752.048 | 32,481.967 | 28,351.801 | 25,197.459 | 27,839.156 | 25,176.28 | 20,155.408 | 33,405.394 | 11,111.8 | 10,282.424 | 6,368.84 | 7,188.425 | 8,327.605 | 12,262.427 |
| Cost of Revenue
| 41,272.191 | 36,362.213 | 27,437.929 | 19,972.757 | 19,450.782 | 16,548.115 | 17,128.54 | 17,622.292 | 19,624.949 | 16,307.551 | 24,655.567 | 9,783.547 | 11,908.728 | 4,641.839 | 5,062.165 | 6,244.603 | 7,027.557 |
| Gross Profit
| 14,955.188 | 23,819.594 | 23,455.617 | 17,779.291 | 13,031.185 | 11,803.686 | 8,068.919 | 10,216.864 | 5,551.331 | 3,847.857 | 8,749.827 | 1,328.253 | -1,626.304 | 1,727.001 | 2,126.26 | 2,083.002 | 5,234.87 |
| Gross Profit Ratio
| 0.266 | 0.396 | 0.461 | 0.471 | 0.401 | 0.416 | 0.32 | 0.367 | 0.22 | 0.191 | 0.262 | 0.12 | -0.158 | 0.271 | 0.296 | 0.25 | 0.427 |
| Reseach & Development Expenses
| 6,861.309 | 6,884.276 | 6,994.159 | 4,308.449 | 4,873.253 | 4,505.04 | 3,602.791 | 2,734.142 | 1,756.986 | 1,219.391 | 762.26 | 418.36 | 366.601 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1,620.389 | 1,504.934 | 384.599 | 347.76 | 448.877 | 551.107 | 483.142 | 605.893 | 726.775 | 670.568 | 1,207.692 | 1,083.583 | 1,034.714 | 597.63 | 266.686 | 241.777 | 336.047 |
| Selling & Marketing Expenses
| 1,345.781 | 908.529 | 1,678.119 | 1,160.29 | 1,212.972 | 2,126.9 | 1,587.003 | 1,869.769 | 1,484.248 | 2,677.925 | 2,823.23 | 3,375.893 | 3,636.461 | 2,964.673 | 2,001.997 | 3,030.118 | 4,381.629 |
| SG&A
| 7,142.882 | 2,413.463 | 2,062.718 | 1,508.05 | 1,661.849 | 2,678.007 | 2,070.145 | 2,475.662 | 2,211.023 | 3,348.493 | 4,030.922 | 4,459.476 | 4,671.175 | 3,562.303 | 2,268.683 | 3,271.895 | 4,717.676 |
| Other Expenses
| 1,165.383 | 5,648.488 | 6,788.079 | 4,729.282 | 4,532.498 | -36.3 | 17.349 | 838.852 | -818.234 | -3,086.557 | 182.242 | -257.075 | 108.972 | -1,131.402 | 400.599 | 540.682 | 1,657.694 |
| Operating Expenses
| 14,004.191 | 14,946.227 | 15,844.956 | 10,545.781 | 11,067.6 | 11,543.507 | 12,528.171 | 12,082.555 | 11,083.343 | 12,265.237 | 16,386.797 | 15,360.487 | 13,567.964 | 10,917.683 | 4,613.024 | 5,422.803 | 7,299.204 |
| Operating Income
| 950.996 | 8,873.367 | 7,610.617 | 7,233.379 | 1,963.585 | 260.179 | -4,459.253 | -1,865.691 | -5,532.014 | -8,417.38 | -7,636.968 | -14,032.233 | -16,310.406 | -9,190.681 | -2,486.763 | -3,339.802 | -2,064.335 |
| Operating Income Ratio
| 0.017 | 0.147 | 0.15 | 0.192 | 0.06 | 0.009 | -0.177 | -0.067 | -0.22 | -0.418 | -0.229 | -1.263 | -1.586 | -1.443 | -0.346 | -0.401 | -0.168 |
| Total Other Income Expenses Net
| 3,781.061 | -2,904.409 | 1,902.722 | -1,991.577 | 479.544 | -12,941.063 | -34,737.359 | 1,188.979 | -858.199 | -20,351.057 | -18,063.995 | -2,647.436 | -3,277.156 | -4,641.897 | -1,446.927 | 338.909 | 1,156.474 |
| Income Before Tax
| 4,732.057 | 5,968.958 | 9,513.338 | 5,241.801 | 2,443.128 | -12,680.884 | -39,196.611 | -676.712 | -6,390.212 | -28,768.437 | -25,700.965 | -16,679.67 | -18,471.425 | -13,832.579 | -3,933.691 | -3,000.892 | -907.86 |
| Income Before Tax Ratio
| 0.084 | 0.099 | 0.187 | 0.139 | 0.075 | -0.447 | -1.556 | -0.024 | -0.254 | -1.427 | -0.769 | -1.501 | -1.796 | -2.172 | -0.547 | -0.36 | -0.074 |
| Income Tax Expense
| 1,154.074 | -4,915.804 | 377.717 | 761.953 | -1,904 | -12,884.306 | 34,395.902 | 1,366.94 | -412.473 | -3,505.652 | -313.519 | 969.804 | -285.469 | -3,535.666 | 19.522 | 2,278.87 | 1,773.289 |
| Net Income
| 3,577.984 | 8,261.769 | 9,450.907 | 5,241.801 | 4,347.128 | -12,680.884 | -39,196.611 | -676.712 | -6,390.212 | -28,768.437 | -25,700.635 | -17,642.755 | -18,172.653 | -13,832.579 | -3,953.213 | -4,432.368 | -907.86 |
| Net Income Ratio
| 0.064 | 0.137 | 0.186 | 0.139 | 0.134 | -0.447 | -1.556 | -0.024 | -0.254 | -1.427 | -0.769 | -1.588 | -1.767 | -2.172 | -0.55 | -0.532 | -0.074 |
| EPS
| 59.63 | 137.79 | 157.66 | 87.44 | 72.52 | -214 | -671.27 | -12 | -115.17 | -619 | -607.88 | -467 | -694.74 | -667.5 | -257.5 | -265.3 | -68.8 |
| EPS Diluted
| 59.63 | 137.79 | 157.66 | 87.44 | 72.52 | -214 | -671.1 | -12 | -115 | -619 | -607.88 | -467 | -694.74 | -667.5 | -257.5 | -265.3 | -68.8 |
| EBITDA
| 3,792.404 | 13,684.304 | 11,626.9 | 7,772.984 | 4,388.475 | 2,129.336 | 33,262.472 | 2,847.527 | -3,354.291 | -9,135.778 | -4,351.54 | -11,881.389 | -14,241.31 | -12,290.245 | -2,549.607 | -1,957.125 | 443.66 |
| EBITDA Ratio
| 0.067 | 0.227 | 0.228 | 0.206 | 0.135 | 0.075 | 1.32 | 0.102 | -0.133 | -0.453 | -0.13 | -1.069 | -1.385 | -1.93 | -0.355 | -0.235 | 0.036 |